Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Declare Drugs Insecurity in Country, Pharmacists Urge FG

Worried by the rising cases of drug diversion, illicit trafficking and counterfeit medicines which have serious consequences in the healthcare services, the Pharmaceutical Society of Nigeria (PSN) has called on

The Pharmaceutical Society of Nigeria (PSN) has urged the federal government to declare pharmaceutical insecurity in the country, citing rising drug diversion, illicit trafficking and counterfeit medicines as serious threats to healthcare services. PSN President, Ayuba Ibrahim Tanko, highlighted the importance of the government's direct involvement in the pharmaceutical supply chain and logistics, warning that the current arrangement leaves the management of medicines too susceptible to private interests and free distribution.

Tanko emphasized that drugs are critical to public health and national security, and their regulation should be under direct government supervision. He stressed that the Constitution places drugs and poisons on the Exclusive Legislative List, underscoring the need for permanent public regulatory control. The House of Representatives' rejection of a bill to move drugs and poisons to the Concurrent List further reinforced this position.

The current model of handing over the supply chain of all public facilities to a private company, according to Tanko, undermines inter-agency collaboration and compromises the cooperation between government bodies and regulatory agencies. He proposed the establishment of a Federal Drug Management Agency with transparent, accountable and legally protected framework for medicine procurement, distribution and management, as well as the integration of community pharmacists into the national security architecture.

Written by urgent.news from This Day's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at thisdaylive.com →

More in Health & Medicine

US regulator investigates tumour risk in children given Novartis gene therapy

The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated with Novartis’ gene therapy Zolgensma. The Swiss drug maker earlier in the day disclosed two cases in which tumours in children showed evidence of being linked to its gene therapy drug used to…

More from Saturday 7 November →